52 filings
Page 2 of 3
8-K
pi95j1ab5yk
9 Jan 23
Royalty Pharma Highlights Accomplishments and Provides Business Update at 41ST Annual J.P. Morgan Healthcare Conference
9:26am
8-K
oft bhsd8ymnv7hkoh7
1 Dec 22
Material Impairments
4:54pm
8-K
0rm1cvp
8 Nov 22
Results of Operations and Financial Condition
7:32am
8-K
ifwecoki z1okqk6oiv5
3 Oct 22
Amendments to Articles of Incorporation or Bylaws
5:06pm
8-K
adqbqnc4j0qhvhri
4 Aug 22
Results of Operations and Financial Condition
7:36am
8-K
74pl4a0
13 Jul 22
Royalty Pharma Agrees to Acquire Royalty Interest In Trelegy
4:34pm
8-K
phr3cy0wxg5d00e
23 Jun 22
Submission of Matters to a Vote of Security Holders
5:13pm
8-K
egdovq
17 May 22
Royalty Pharma Investor Day Highlights Stronger Growth Outlook and the Power of Its Unique Business Model to Drive Value for All Stakeholders
7:37am
8-K
c5rowl1qbg7
11 May 22
Other Events
11:32am
8-K
1r1l360
5 May 22
Results of Operations and Financial Condition
7:37am
8-K
x9vsx4ewmg7n
15 Apr 22
Other Events
4:22pm
8-K
mdochwv2uxvvb1bb kw
4 Apr 22
Changes in Registrant's Certifying Accountant
4:57pm
8-K
8yaiibe2
15 Feb 22
Results of Operations and Financial Condition
7:55am
8-K
h7vmkq0 iz
10 Jan 22
Royalty Pharma Highlights Accomplishments and Provides Business Update at 40TH Annual J.P. Morgan Healthcare Conference
7:37am
8-K
fg38mbaw
10 Nov 21
Results of Operations and Financial Condition
7:59am
8-K
ai9bbc69m ipuhhfq2f
11 Aug 21
Results of Operations and Financial Condition
7:47am
8-K
4ixyt
26 Jul 21
Entry into a Material Definitive Agreement
5:00pm
8-K
zu8nb7si7nble
16 Jul 21
Entry into a Material Definitive Agreement
5:11pm
8-K
xr22xn
25 Jun 21
Submission of Matters to a Vote of Security Holders
5:21pm
8-K
kdku s200i329mggp4
2 Jun 21
Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership with Morphosys
7:51am